DK363186A - (4-substituerede-piperazinyl)pyridaziner - Google Patents

(4-substituerede-piperazinyl)pyridaziner Download PDF

Info

Publication number
DK363186A
DK363186A DK363186A DK363186A DK363186A DK 363186 A DK363186 A DK 363186A DK 363186 A DK363186 A DK 363186A DK 363186 A DK363186 A DK 363186A DK 363186 A DK363186 A DK 363186A
Authority
DK
Denmark
Prior art keywords
pyridazines
piperazinyl
substituted
Prior art date
Application number
DK363186A
Other languages
Danish (da)
English (en)
Other versions
DK363186D0 (da
Inventor
Raymond A Stokbroekx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK363186D0 publication Critical patent/DK363186D0/da
Publication of DK363186A publication Critical patent/DK363186A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK363186A 1985-07-31 1986-07-30 (4-substituerede-piperazinyl)pyridaziner DK363186A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76084585A 1985-07-31 1985-07-31

Publications (2)

Publication Number Publication Date
DK363186D0 DK363186D0 (da) 1986-07-30
DK363186A true DK363186A (da) 1987-02-01

Family

ID=25060338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK363186A DK363186A (da) 1985-07-31 1986-07-30 (4-substituerede-piperazinyl)pyridaziner

Country Status (18)

Country Link
EP (1) EP0211457A3 (fr)
JP (1) JPS6229575A (fr)
KR (1) KR870001192A (fr)
CN (1) CN86105558A (fr)
AU (1) AU6073986A (fr)
DK (1) DK363186A (fr)
ES (1) ES8802151A1 (fr)
FI (1) FI863120A (fr)
GR (1) GR862022B (fr)
HU (1) HU195501B (fr)
IL (1) IL79549A0 (fr)
NO (1) NO863083L (fr)
NZ (1) NZ216918A (fr)
PH (1) PH22884A (fr)
PT (1) PT83098B (fr)
TN (1) TNSN86117A1 (fr)
ZA (1) ZA865700B (fr)
ZW (1) ZW14886A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104343A (en) * 1987-11-23 1994-03-31 Janssen Pharmaceutica Nv Novel pyridizinamine deravatives
US4992433A (en) * 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
US5270312A (en) * 1990-11-05 1993-12-14 Warner-Lambert Company Substituted piperazines as central nervous system agents
ATE491689T1 (de) * 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
AU773830B2 (en) * 1999-04-26 2004-06-10 Neurosearch A/S Heteroaryl diazacycloalkanes, their preparation and use
EP1430033A4 (fr) 2001-08-31 2004-12-15 Univ Northwestern Composition anti-inflammatoire et inhibitrice de la proteine kinase et methode d'utilisation
US7390813B1 (en) 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
WO2005011655A2 (fr) 2003-07-30 2005-02-10 Xenon Pharmaceuticals Inc. Derives de pyridazine et leur utilisation en tant qu'agents therapeutiques
US7754711B2 (en) * 2003-07-30 2010-07-13 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
KR20060037410A (ko) 2003-07-30 2006-05-03 제논 파마슈티칼스 인크. 피리다진 유도체 및 그의 치료제로서의 용도
US7759348B2 (en) 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
US7592343B2 (en) 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
EP1799668A1 (fr) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant que modulateurs de stearoyle-coa desaturase
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
WO2006034341A2 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
CA2580787A1 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et utilisation de ceux-ci comme agents therapeutiques
JP4958786B2 (ja) 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
ES2543813T3 (es) 2004-11-02 2015-08-24 Northwestern University Compuestos de piridazina para el tratamiento de enfermedades inflamatorias
WO2006050359A2 (fr) 2004-11-02 2006-05-11 Northwestern University Composes pyridazine et methodes
AU2016203312B2 (en) * 2004-11-02 2018-05-24 Centre National De La Recherche Scientifique Pyridazine compounds, compositions and methods
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
WO2007127474A2 (fr) 2006-04-28 2007-11-08 Northwestern University Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinestérase
WO2007127375A2 (fr) 2006-04-28 2007-11-08 Northwestern University Formulations contenant un composé de pyridazine
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
CA2682671C (fr) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles en tant qu'antagonistes du recepteur de la dopamine a dissociation rapide
CN101663292A (zh) 2007-04-23 2010-03-03 詹森药业有限公司 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物
US8653262B2 (en) * 2007-05-31 2014-02-18 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists and uses thereof
LT2307374T (lt) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai
EP2714665A1 (fr) 2011-05-24 2014-04-09 Università degli Studi di Bari "Aldo Moro" Nouveaux ligands 1-arylpipéraziniques de récepteur 5-ht7 et utilisation de ceux-ci
WO2017004537A1 (fr) 2015-07-02 2017-01-05 Centrexion Therapeutics Corporation Citrate de (4-((3r,4r)-3-méthoxytétrahydro-pyran-4-ylamino)pipéridin-1-yl)(5-méthyl-6-(((2r,6s)-(p-tolyl)tétrahydro-2h-pyran-2-yl)méthylamino)pyrimidin-4-yl)méthanone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines

Also Published As

Publication number Publication date
EP0211457A2 (fr) 1987-02-25
FI863120A0 (fi) 1986-07-30
NZ216918A (en) 1988-11-29
PT83098A (en) 1986-08-01
PH22884A (en) 1989-01-19
FI863120A (fi) 1987-02-01
ZW14886A1 (en) 1988-02-24
ES8802151A1 (es) 1988-04-01
IL79549A0 (en) 1986-10-31
PT83098B (en) 1988-07-13
HUT41772A (en) 1987-05-28
CN86105558A (zh) 1987-01-28
EP0211457A3 (fr) 1987-07-22
KR870001192A (ko) 1987-03-12
TNSN86117A1 (fr) 1990-01-01
DK363186D0 (da) 1986-07-30
JPS6229575A (ja) 1987-02-07
NO863083L (no) 1987-02-02
NO863083D0 (no) 1986-07-30
GR862022B (en) 1986-12-24
HU195501B (en) 1988-05-30
ES556738A0 (es) 1988-04-01
AU6073986A (en) 1987-02-05
ZA865700B (en) 1988-03-30

Similar Documents

Publication Publication Date Title
DK363186D0 (da) (4-substituerede-piperazinyl)pyridaziner
LU90099I2 (fr) Fluodioxonil (celest)
BR8605872A (pt) Combinada(ceifadeira-trilhadeira)
DK140587A (da) Selvhaerdende urethanklaebepasta
IT1197151B (it) Sottomaterasso
BR8600694A (pt) Conjunto alternador-compressor
ATA155686A (de) Giesspfannenkopf
NO168368C (no) Smoereoljeblanding
DK566386A (da) Vandtaarn
AT386920B (de) Maishaecksler
NO171144C (no) Benfiskeringssystem
ATA122686A (de) Kettenschloss
DK164026C (da) Blikdaase
IT8621669A1 (it) Guidastoppino
KR870002798U (ko) 장구
ATA257585A (de) Ru-deruebungsgeraet
DK111685A (da) Letvaeskespaerre
ATA173385A (de) Stiegenlift
SE8505938D0 (sv) Fotpall (fotvagga)
KR870003739U (ko) 캐스터(caster)
ES284372Y (es) Estuche porta-casete
ES285725Y (es) Estuche
BR8501500A (pt) Aperfeicoamentos em biodigestor
BR6500952U (pt) Estojo
ES286978Y (es) Ficha-contenedor

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment